{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP00513",
    "Peptide Name": "Ranalexin   (natural AMPs; frog, amphibians, animals; ZZP; XXU; 1S=S, UCSS1a)",
    "Source": "Bull frog,Rana catesbeiana, North America",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "FLGGLIKIVPAMICAVTKKC",
    "Sequence Length": 20,
    "UniProt Entry": "P39084",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Antifungal",
      "Antiparasitic",
      "Anti-MRSA",
      "Synergistic AMPs",
      "Anticancer"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 3,
    "Boman Index": -1.34,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "65%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Activity: active as the WT against S. aureus or MRSA (MIC 4 ug/ml), P.aeruginosa (MIC 128 ug/ml), E. coli (MIC 32 ug/ml).In vitro toxicity: The recombinant ranalexin is also cytotoxic in HeLa and COS7 human cancer cells (IC50 =13-15 ug/ml)(Appl Microbiol Biotechnol. 2012).Structure:  In membrane-mimetic TFE or DPC micelles, residues 8-15 are helical (edited 11/4/2007 GW).Animal model:mouse:bacteria: In mice for systemic infection, the peptide showed synergistic effect against MRSA with antistaphylococcal endopeptidase (Desbois AP et al., 2010 Int J Antimicrob Agents 35: 559-65).Synergy:enzyme: see above.Updated 10/12/2012; 9/2024 GW.",
    "Author": "Clark DP, Durell S, Maloy WL, Zasloff M1994",
    "Reference": "J Biol Chem 1994; 269: 10849-10855.(Clark et al., 1994)",
    "Title": "Ranalexin, a novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin"
  },
  "3D Structure": []
}